Article metrics
PDF
Other content recommended for you
- Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP
- Comparison of the diagnostic accuracy of the 2021 EAN/PNS and 2010 EFNS/PNS diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy
- CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS
- Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database
- Clinicopathological characteristics of subtypes of chronic inflammatory demyelinating polyradiculoneuropathy
- Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy
- Chronic inflammatory demyelinating polyradiculoneuropathy in solid organ transplant recipients: a prospective study
- Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy
- New classification of autoimmune neuropathies based on target antigens and involved domains of myelinated fibres
- POEMS neuropathy: optimising diagnosis and management